The huge American Society of Clinical Oncology or ASCO confab has called it a wrap for another yearWe covered some of the winners and losers from the event in yesterday's column. Today, we look at a few small cap bargains in the biotech and biopharma spaceLet's start with Dynavax Technologies (DVAX) which provided an update on a Phase 1/2 trial in...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.